Vault-13

Birchview Capital, LP

BURLINGTON, VT · CIK 1618205 · 13F filing filed 2020-02-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$137.6m reported value
52positions
79.1%in top 10
—no comparable previous quarter

Holdings, Q4 2019

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BRISTOL-MYERS SQUIBB CO COM BMY BMY 778,585 $50.0m36.33% 36.33% —
2 ACCELERATE DIAGNOSTICS INC COM COM 2,183,795 $36.9m26.83% 26.83% —
3 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 55,000 $5.9m4.30% 4.30% —
4 QUIDEL CORP COM QDEL QDEL 48,844 $3.7m2.66% 2.66% —
5 OXFORD IMMUNOTEC GLOBAL PLC ORD SHS OXFD OXFD 170,303 $2.8m2.05% 2.05% —
6 VERMILLION INC COM NEW COM NEW 3,221,933 $2.6m1.90% 1.90% —
7 BRISTOL-MYERS SQUIBB CO RIGHT 99/99/9999 BMY-R BMY-R 699,648 $2.1m1.53% 1.53% —
8 CONTRAFECT CORP COM CFRX CFRX 2,827,003 $1.8m1.28% 1.28% —
9 EQM MIDSTREAM PARTNERS LP UNIT LTD PARTN EQM EQM 51,250 $1.5m1.12% 1.12% —
10 KARYOPHARM THERAPEUTICS INC COM COM 80,000 $1.5m1.12% 1.12% —
11 SOLENO THERAPEUTICS INC COM COM 510,598 $1.5m1.09% 1.09% —
12 BIOGEN INC COM BIIB BIIB 5,000 $1.5m1.08% 1.08% —
13 HARROW INC COM HROW HROW 180,000 $1.4m1.02% 1.02% —
14 VANDA PHARMACEUTICALS INC COM VNDA VNDA 80,000 $1.3m0.95% 0.95% —
15 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 59,000 $1.3m0.92% 0.92% —
16 MASIMO CORP COM MASI MASI 8,000 $1.3m0.92% 0.92% —
17 ARVINAS INC COM ARVN ARVN 30,000 $1.2m0.90% 0.90% —
18 ALBIREO PHARMA INC COM BIOD BIOD 48,000 $1.2m0.89% 0.89% —
19 DERMIRA INC COM DERM DERM 80,000 $1.2m0.88% 0.88% —
20 G1 THERAPEUTICS INC COM GTHX GTHX 40,000 $1.1m0.77% 0.77% —
21 INTERCEPT PHARMACEUTICALS IN COM ICPT ICPT 8,300 $1.0m0.75% 0.75% —
22 ARENA PHARMACEUTICALS INC COM NEW ARNA ARNA 22,000 $999.0k0.73% 0.73% —
23 ACCELERON PHARMA INC COM XLRN XLRN 18,672 $990.0k0.72% 0.72% —
24 CHEMOCENTRYX INC COM CCXI CCXI 25,000 $989.0k0.72% 0.72% —
25 IMMUNOGEN INC COM IMGN IMGN 180,000 $919.0k0.67% 0.67% —
26 WRIGHT MEDICAL GROUP NV COM COM 30,000 $914.0k0.66% 0.66% —
27 MYRIAD GENETICS INC COM MYGN MYGN 30,000 $817.0k0.59% 0.59% —
28 QIAGEN NV SHS NEW SHS NEW 20,000 $676.0k0.49% 0.49% —
29 ODONATE THERAPEUTICS INC COM COM 20,000 $649.0k0.47% 0.47% —
30 CORCEPT THERAPEUTICS INC COM CORT CORT 50,000 $605.0k0.44% 0.44% —
31 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 14,000 $599.0k0.44% 0.44% —
32 PIONEER NAT RES CO COM PXD PXD 3,800 $575.0k0.42% 0.42% —
33 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 10,000 $544.0k0.40% 0.40% —
34 KALVISTA PHARMACEUTICALS INC COM KALV KALV 30,000 $534.0k0.39% 0.39% —
35 GOSSAMER BIO INC COM GOSS GOSS 30,000 $469.0k0.34% 0.34% —
36 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 5,000 $440.0k0.32% 0.32% —
37 XENCOR INC COM XNCR XNCR 12,300 $423.0k0.31% 0.31% —
38 VOYAGER THERAPEUTICS INC COM VYGR VYGR 30,000 $419.0k0.30% 0.30% —
39 PROGYNY INC COM PGNY PGNY 15,000 $412.0k0.30% 0.30% —
40 AMICUS THERAPEUTICS INC COM FOLD FOLD 38,000 $370.0k0.27% 0.27% —
41 SIENTRA INC COM SIEN SIEN 40,000 $358.0k0.26% 0.26% —
42 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 80,000 $332.0k0.24% 0.24% —
43 VERACYTE INC COM VCYT VCYT 10,767 $301.0k0.22% 0.22% —
44 APELLIS PHARMACEUTICALS INC COM APLS APLS 8,000 $245.0k0.18% 0.18% —
45 ENCANA CORP COM COM 49,550 $232.0k0.17% 0.17% —
46 DICERNA PHARMACEUTICALS INC COM DRNA DRNA 10,000 $220.0k0.16% 0.16% —
47 CONTINENTAL RES INC COM CLR CLR 6,000 $206.0k0.15% 0.15% —
48 TG THERAPEUTICS INC COM TGTX TGTX 15,000 $167.0k0.12% 0.12% —
49 YIELD10 BIOSCIENCE INC COM COM 758,159 $130.0k0.09% 0.09% —
50 LIVENT CORP COM COM 10,000 $86.0k0.06% 0.06% —
51 WORKHORSE GROUP INC COM NEW COM NEW 25,000 $76.0k0.06% 0.06% —
52 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 20,000 $69.0k0.05% 0.05% —